- Home
- CVM vs JAGU Comparison
CVM vs JAGU Comparison
Compare CVM & JAGU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CVM | JAGU |
|---|---|---|
| Founded | 1983 | 2022 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.1M | 29.1M |
| IPO Year | 1996 | 2025 |
Fundamental Metrics
Financial Performance| Metric | CVM | JAGU |
|---|---|---|
| Price | $2.16 | $1.13 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $12.50 | N/A |
| AVG Volume (30 Days) | ★ 197.3K | 185.5K |
| Earning Date | 11-05-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 68.67 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $264,033.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 65.45 | N/A |
| 52 Week Low | $0.89 | $1.05 |
| 52 Week High | $10.39 | $3.60 |
Technical Indicators
Market Signals| Indicator | CVM | JAGU |
|---|---|---|
| Relative Strength Index (RSI) | 59.37 | 29.95 |
| Support Level | $1.01 | N/A |
| Resistance Level | $4.84 | $1.76 |
| Average True Range (ATR) | 0.22 | 0.15 |
| MACD | 0.08 | -0.04 |
| Stochastic Oscillator | 48.51 | 10.67 |
Price Performance
Historical ComparisonAbout CVM Cel-Sci Corporation
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.
About JAGU Jaguar Uranium Corp. Class A Common Shares
Jaguar Uranium Corp is a uranium exploration and development company focused on uranium discoveries. The company is a junior miner engaged in uranium exploration. Its portfolio is comprised of two uranium exploration projects in Argentina and one uranium exploration project in Colombia. Its projects include the Berlin Project, the Laguna Project, and the Huemul Project. The company operates in one reportable segment which is the exploration and evaluation of mineral properties.